ABVC BIOPHARMA, INC. Logo

ABVC BIOPHARMA, INC.

Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.

ABVC | US

Overview

Corporate Details

ISIN(s):
US00091F1066
LEI:
Country:
United States of America
Address:
44370 OLD WARM SPRINGS BLVD., 94538 FREMONT

Description

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes drugs and medical devices to address unmet medical needs. The company focuses on advancing a pipeline of botanical, plant-based pharmaceuticals and medical technologies sourced from research institutions. Its therapeutic areas of focus include oncology, ophthalmology, and central nervous system disorders such as major depressive disorder (MDD) and adult attention-deficit/hyperactivity disorder (ADHD). Key products in development include Vitargus®, a biodegradable vitreous substitute for eye surgery, and botanical drug candidates for MDD and ADHD. Additionally, its subsidiary, BioKey, Inc., offers contract development and manufacturing services for nutritional and pharmaceutical products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2017-09-20 17:00
CURRENT REPORT
English ZIP 40.4 KB
2017-08-21 18:36
QUARTERLY REPORT
English ZIP 728.5 KB
2017-08-14 15:33
NOTIFICATION OF LATE FILING
English ZIP 11.0 KB
2017-07-26 14:29 English ZIP 203.0 KB
2017-07-24 17:47
FORM 8-K
English ZIP 22.8 KB
2017-07-17 19:20 English ZIP 48.9 KB
2017-07-17 19:20
AMENDMENT NO. 4 TO REGISTRATION STATEMENT
English ZIP 1.2 MB
2017-06-20 18:09 English ZIP 183.9 KB
2017-06-15 15:15 English ZIP 211.3 KB
2017-05-30 18:29
CURRENT REPORT
English ZIP 23.0 KB
2017-05-24 19:31
AMENDMENT NO. 3 TO REGISTRATION STATEMENT
English ZIP 1.2 MB
2017-05-24 19:30 English ZIP 19.6 KB
2017-05-22 19:07
AMENDMENT NO.2 TO ANNUAL REPORT
English ZIP 674.0 KB
2017-05-22 18:40
AMENDMENT NO. 1 TO QUARTERLY REPORT
English ZIP 510.4 KB
2017-05-22 17:02
QUARTERLY REPORT
English ZIP 698.8 KB

Automate Your Workflow. Get a real-time feed of all ABVC BIOPHARMA, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ABVC BIOPHARMA, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ABVC BIOPHARMA, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BASKHANBIOPharma Inc. Logo
Offers pharmaceuticals, medical devices, and health products for pain management.
South Korea
354390
Bausch Health Companies Inc. Logo
Develops, manufactures, and markets pharmaceuticals, OTC products, and medical devices.
United States of America
BHC
Bausch & Lomb Corp Logo
Global eye health company offering vision care, pharmaceutical, and surgical products.
United States of America
BLCO
Bavarian Nordic Logo
Biotechnology company developing and commercializing vaccines for infectious diseases.
Denmark
BAVA
BAXTER INTERNATIONAL INC Logo
Provides essential products for renal care, hospital, and surgical settings.
United States of America
BAX
Bayer AG Logo
A global life science company with core competencies in healthcare and nutrition.
Germany
BAY
BBS-Bioactive Bone Substitutes Oyj Logo
Develops and manufactures bioactive medical implants for orthopedic surgery.
Finland
BONE
BCWORLDPHARM Co., Ltd. Logo
Pharmaceutical company specializing in the R&D and manufacturing of prescription drugs.
South Korea
200780
Beam Therapeutics Inc. Logo
Develops precision genetic medicines using proprietary base editing technology.
United States of America
BEAM
BELITE BIO, INC Logo
Clinical-stage biopharma developing therapies for retinal and metabolic diseases.
United States of America
BLTE

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.